In this randomized pilot study , patients were allocated to receive fibrinogen concentrate ( 60 mg/kg ) or cryoprecipitate ( 10 mL/kg ) if bleeding was associated with fibrinogen levels < 1 g/dL after cardiopulmonary bypass weaning .